Article
The VEGFR2, COX-2 and MMP-2 polymorphisms are associated with clinical outcome of patients with inoperable non-small cell lung cancer.
International journal of cancer - 15 Nov 2015
Butkiewicz Dorota, Krześniak Małgorzata, Drosik Anna, Giglok Monika, Gdowicz-Kłosok Agnieszka, Kosarewicz Agata, Rusin Marek, Masłyk Barbara, Gawkowska-Suwińska Marzena, Suwiński Rafał
Abstract excerpt
Certain common inherited variations in genes involved in tumor angiogenesis, progression and metastasis may contribute to cancer therapy outcome and prognosis by altering the gene expression and protein activity. In this report, we examined the effect of functional polymorphisms in MMP-1, MMP-2, MMP-3, VEGF, VEGFR2, FGFR4 and COX-2 genes on overall (OS) and progression-free survival (PFS) of 350 Caucasian...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
